# Fruquintinib With or Without HAI-FOLFOX for Refractory Colorectal Cancer

Source: https://onco.cc/trials/nct06441565/  
OnCo record `nct06441565` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2/3 trial of fruquintinib, fluorouracil (5-FU) and fOLFOX (5-FU, leucovorin, oxaliplatin) in colorectal cancer, run by Sun Yat-sen University, now recruiting.

## Summary

Fruquintinib With or Without HAI-FOLFOX for Refractory Colorectal Cancer is a phase 2/3, randomised interventional study registered as NCT06441565 by Sun Yat-sen University, with a registry enrolment figure of 84 participants, started 2024-05-24 and due to reach its primary completion in 2025-12-30. Interventions recorded: Fruquintinib; Fluorouracil; Oxaliplatin. Conditions listed: Colorectal Cancer. Primary outcome: 6-month progression-free survival. Colorectal eligibility wording from the registry: "* Histologically confirmed colorectal adenocarcinoma". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT06441565
- Phase: 2/3
- Setting: Fruquintinib Plus Arterial Infusion Therapy With Hepatic FOLFOX for Refractory Colorectal Cancer: The FAITH Randomized Clinical Trial
- Sponsor: Sun Yat-sen University
- Enrolled: 84

## Sources

- ClinicalTrials.gov NCT06441565: https://clinicaltrials.gov/study/NCT06441565

## Connected records

- cancers: [Colon cancer (adenocarcinoma of the colon)](https://onco.cc/cancers/colon-cancer/), [Rectal cancer](https://onco.cc/cancers/rectal-cancer/)
- technologies: [Anti-angiogenic therapy](https://onco.cc/technologies/antiangiogenic/), [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/), [Platinum agents](https://onco.cc/technologies/platinum/), [Small-molecule kinase inhibitors](https://onco.cc/technologies/kinase-inhibitors/)
- drugs: [Fluorouracil (5-FU)](https://onco.cc/drugs/fluorouracil/), [FOLFOX (5-FU, leucovorin, oxaliplatin)](https://onco.cc/drugs/folfox/), [Fruquintinib](https://onco.cc/drugs/fruquintinib/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06441565.json